Characterization of PTEN mutations in brain cancer reveals that pten mono-ubiquitination promotes protein stability

Jr-M Yang1, P Schiapparelli2,3, H-N Nguyen1

  • 1Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Oncogene
|March 7, 2017
PubMed

Insights

Mutations in the PTEN tumor suppressor can disrupt its cellular localization and stability without affecting its enzymatic activity, offering new therapeutic targets for brain cancers like glioblastoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • PTEN (Phosphatase and tensin homolog) is a crucial tumor suppressor that counteracts PI3K/AKT signaling.
  • PTEN mutations are frequent in cancers, particularly glioblastoma, often leading to loss of function.
  • Current understanding suggests PTEN deficiency stems mainly from reduced expression or enzymatic inactivity.

Purpose of the Study:

  • To investigate novel mechanisms of PTEN dysfunction in glioblastoma beyond loss of expression or enzymatic activity.
  • To identify specific PTEN mutations affecting its localization and stability.
  • To explore therapeutic strategies targeting PTEN regulation in brain tumors.

Main Methods:

  • Analysis of PTEN in primary malignant glioblastoma cells from 16 patients.
  • Cellular and biochemical assays to assess PTEN localization, lipid phosphatase activity, and ubiquitination.
  • Structural modeling to understand the impact of mutations on PTEN conformation.
  • Investigation of the effects of mono-ubiquitination on mutant PTEN stability and localization.

Main Results:

  • Identified PTEN mutations in glioblastoma that impair plasma membrane and nuclear localization without altering lipid phosphatase activity.
  • Demonstrated that two specific mutations disrupt intramolecular PTEN interactions, leading to an open conformation.
  • Observed that these mutations enhance PTEN polyubiquitination and decrease protein stability.
  • Found that promoting PTEN mono-ubiquitination enhances the stability and nuclear localization of mutant PTEN.

Conclusions:

  • Discovered a molecular mechanism for cancer-associated PTEN defects involving impaired localization and stability.
  • Established that PTEN mutations can disrupt its conformation and increase susceptibility to degradation.
  • Proposed that targeting PTEN mono-ubiquitination represents a potential therapeutic avenue for brain cancers.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.9K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
3.2K